Hide Filters
Showing 2719 results
  • Event /

    Novartis Financial Results – Q3 2019

    Novartis announced the company’s financial results for the third quarter of 2019.

  • Building belonging

  • The inflammasome
    Story /

    Breaking a vicious cycle of inflammation

    Discovery

    Novartis researchers aim to quash inflammation to treat chronic disease.

  • Young African family lives every day with the threat of malaria
    Story /

    African experts call for renewed global drive to beat malaria

    Access to Healthcare

    Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.

  • CAR-T Cell Therapy: Pioneering Cancer Therapy

  • AI image overlay of pathology image
    Story /

    Artificial intelligence decodes cancer pathology images

    Discovery

    Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

  • The Pioneers of CAR-T Cell and Gene Therapy

  • Press release /

    New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

    NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results…

  • Careers

  • Fixed-income securities